Reply: Platelet Reactivity Is Preferred Over Genotyping in Monitoring Efficacy of Antiplatelet Therapy

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JACC. Cardiovascular interventions 2014-04, Vol.7 (4), p.448-449
Hauptverfasser:	Viviani Anselmi, Chiara, Briguori, Carlo, Roncarati, Roberta, Papa, Laura, Visconti, Gabriella, Focaccio, Amelia, De Micco, Francesca, Latronico, Michael V.G., Pagnotta, Paolo, Condorelli, Gianluigi
Format:	Artikel
Sprache:	eng
Schlagworte:	Aryl Hydrocarbon Hydroxylases - genetics Coronary Artery Disease - therapy Drug-Eluting Stents Female Humans Male Percutaneous Coronary Intervention - instrumentation Platelet Aggregation - drug effects Platelet Aggregation Inhibitors - therapeutic use Polymorphism, Genetic Ticlopidine - analogs & derivatives
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!